Viking Global Investors
Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.
Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.
View Older Stories View More Recent Stories
-
Druva Extends Platform With Most Comprehensive Protection and Automation for Cloud Workloads
-
Druva Welcomes New General Counsel and Chief Technologist
-
Pizza? Brunch? IMPOSSIBLE™! DoorDash and Impossible Foods Partner to Launch Impossible Cuisine Category, Offers $0 Delivery Fees in Celebration
-
Hawaiian Institution Minit Stop Replaces Beef With Award-Winning Impossible Burger
-
Impossible Foods Hires Jessie Becker as Senior Vice President of Marketing
-
Druva Showcases How to Accelerate the Journey to Cloud at VMworld
-
Ginkgo Bioworks Announces the Ferment Consortium, a $350 Million Investment Vehicle to Disrupt Established Markets with New Synthetic Biology Companies
-
Ginkgo Bioworks raises $350 million fund for biotech spinouts
-
Impossible Burger Becomes No. 1 Item Sold at Grocery Stores
-
Impossible Foods Hires Dan Greene as Senior Vice President of US Sales
-
Druva Recognized for Continued Innovation with Three New Patents For Data Management
-
Impossible Foods Wins UN Global Climate Action Award in “Planetary Health” Category
-
Impossible Foods Makes East Coast Grocery Store Debut
-
Rockefeller Capital Management Appoints Shelly Lazarus, Marty Mannion as Independent Directors to Board
-
Impossible Foods Makes Global Grocery Store Debut at Gelson’s
-
Kroger First to Take Apeel Produce Coast-to-Coast
-
Private Client Resources (PCR) Expands Management Team with Key C-Suite Executives
-
SeaWorld Parks & Entertainment Rolls Out Impossible™ Burger to Park Menus
-
White Castle® Celebrates First Anniversary of Making Impossible™ Slider a Permanent Menu Item In All Castle Restaurants
-
Leading Independent Research Firm Cites Druva as a Strong Performer for Data Resiliency Solutions
-
Druva Bolsters Executive Team With Talent and Culture Lead
-
J2 Acquisition Ltd. Reports Acquisition of APi Group Inc. for $2.9B
-
J2 Acquisition Limited to Acquire APi Group, Inc. for $2.9 Billion
-
Druva Announces Availability of its Data Protection Platform on VMware Cloud Marketplace™
-
Druva Unveils Industry’s First Multi-Tier Intelligent Data Storage in the Cloud
-
Druva Delivers Data Protection With Built-In Disaster Recovery on AWS
-
Impossible Foods Hires Ravi Thakkar as Vice President of Product Management
-
UPDATE: Viking Global's 13F Shows New Stakes in Uber (UBER), Boeing (BA), Monster Beverage (MNST), Salesforces (CRM) (More...)
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
-
MedAnswers Raises $5 Million Seed Round and Launches First Social Media Feed with Scientifically and Clinically Validated Fertility Resources On The FertilityAnswers App
-
MedAnswers Raises $5 Million Seed Round and Launches First Social Media Feed with Scientifically and Clinically Validated Fertility Resources On The FertilityAnswers App
-
CORRECTING and REPLACING Druva and VMware Bring Data Protection for the Cloud Era to VMworld 2019
-
Druva and VMware Bring Data Protection for the Cloud Era to VMworld 2019
-
Druva Expands Executive Team as Company Continues Phase of Hypergrowth
-
Sodexo Launches New Impossible™ Burger Menu at more than 1,500 U.S. Locations
-
Hedge fund Hoplite Capital plans to shut down - letter
-
BURGER KING® Restaurants Launches the Impossible™ WHOPPER® Nationwide
-
Impossible Foods Receives Approval for Its Color Additive Petition From US Food and Drug Administration
-
Impossible Foods Launches Co-manufacturing Collaboration With OSI
-
Druva Appoints Bill Losch, Okta CFO, to Board of Directors
-
Druva Set to Bring Cloud to the Edge with CloudLanes Acquisition
-
Form SC 13D/A Axovant Gene Therapies Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Arbutus Biopharma Corp For: Jul 10 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Form 4 Arbutus Biopharma Corp For: Jul 10 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Axovant Gene Therapies For: Jul 10 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Form 4 Axovant Gene Therapies For: Jul 10 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Myovant Sciences Ltd. For: Jul 10 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Form 4 Myovant Sciences Ltd. For: Jul 10 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Urovant Sciences Ltd. For: Jul 10 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Form 4 Urovant Sciences Ltd. For: Jul 10 Filed by: VIKING GLOBAL INVESTORS LP


